TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 9363139

Group type: EXPERIMENTAL
Intervention: Intravenous antibiotic therapy changed to oral therapy after being afebrile for 16 hours, able to take antibiotics by mouth, and leukocyte count returning towards normal.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Adjunctive therapy with nutritional supplements and vitamin C.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Yearly immunization with influenza A and B virus vaccine.
Number of subjects: 0
Study: 8335810

Group type: EXPERIMENTAL
Intervention: Atenolol (5 to 10 mg intravenously followed by 25 to 50 mg orally every 12 h)
Number of subjects: 292

Group type: EXPERIMENTAL
Intervention: Alinidine (20 to 40 mg intravenously followed by 20 to 40 mg orally every 8 h)
Number of subjects: 292

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 292
Study: 2417784

Group type: EXPERIMENTAL
Intervention: Albuterol (salbutamol)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 30355202

Group type: EXPERIMENTAL
Intervention: Carotid artery stenting (CAS)
Number of subjects: 4597

Group type: COMPARATOR
Intervention: Carotid endarterectomy (CEA)
Number of subjects: 4597
Study: 29450341

Group type: EXPERIMENTAL
Intervention: TD OCT (Stratus)
Number of subjects: 121

Group type: COMPARATOR
Intervention: SD OCT (Cirrus)
Number of subjects: 121

Group type: EXPERIMENTAL
Intervention: Mathematical conversion equations
Number of subjects: 121
Study: 24645944

Group type: EXPERIMENTAL
Intervention: High-frequency oscillatory ventilation (HFOV)
Number of subjects: 797

Group type: COMPARATOR
Intervention: Conventional ventilation
Number of subjects: 797
Study: 20153269

Group type: EXPERIMENTAL
Intervention: Active cycle of breathing
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Autogenic drainage
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Positive expiratory pressure (PEP)
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Oscillating PEP
Number of subjects: 75

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 75
Study: 18661389

Group type: EXPERIMENTAL
Intervention: Negative life circumstances ads
Number of subjects: 488

Group type: COMPARATOR
Intervention: Control ads
Number of subjects: 488

Group type: EXPERIMENTAL
Intervention: Industry manipulation ads
Number of subjects: 488

Group type: EXPERIMENTAL
Intervention: All ads (including negative life circumstances, control, and industry manipulation)
Number of subjects: 488
Study: 15679494

Group type: EXPERIMENTAL
Intervention: Mechanical bowel preparation with polyethyleneglycol
Number of subjects: 185

Group type: COMPARATOR
Intervention: Control group (no mechanical bowel preparation)
Number of subjects: 185
Study: 12970211

Group type: EXPERIMENTAL
Intervention: Valve Replacement (VR)
Number of subjects: 370

Group type: EXPERIMENTAL
Intervention: Predictors of thromboembolism (TE) following AVR
Number of subjects: 370

Group type: EXPERIMENTAL
Intervention: Predictors of thromboembolism (TE) following MVR/DVR
Number of subjects: 370
Study: 12484313

Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study: 8666763

Group type: EXPERIMENTAL
Intervention: Nursing home residents
Number of subjects: 56

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 56
Study: 1643681

Group type: EXPERIMENTAL
Intervention: Stimulation of musculo-cutaneous nerve and one other nerve (G-2)
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Stimulation of all four major nerves (G-1)
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Stimulation of radial nerve (G-3)
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Stimulation of median nerve (G-4)
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Stimulation of ulnar nerve (G-5)
Number of subjects: 75
Study: 6715723

Group type: EXPERIMENTAL
Intervention: Polymerized ragweed (PRW)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50

Group type: COMPARATOR
Intervention: Untreated
Number of subjects: 50
Study: 31077026

Group type: EXPERIMENTAL
Intervention: Speech therapy intervention (SG)
Number of subjects: 34

Group type: COMPARATOR
Intervention: No intervention (CG)
Number of subjects: 34
Study: 30341114

Group type: EXPERIMENTAL
Intervention: Brief intervention on SNAP (Smoking, Nutrition, Alcohol, and Physical inactivity)
Number of subjects: 824

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 824
Study: 27232978

Group type: EXPERIMENTAL
Intervention: W5″ Test (Five Seconds Power Test)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Training group
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 30
Study: 24009085

Group type: EXPERIMENTAL
Intervention: High maternal warmth at age 5
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: High reported maternal warmth and induction
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: Greater HPA-axis reactivity at age 7
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: Age 5 maternal warmth
Number of subjects: 65
Study: 23259209

Group type: EXPERIMENTAL
Intervention: Tazarotene foam 0.1%
Number of subjects: 14

Group type: COMPARATOR
Intervention: Vehicle foam
Number of subjects: 14
Study: 20484643

Group type: EXPERIMENTAL
Intervention: Vasopressin (40 IU)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 19078836

Group type: EXPERIMENTAL
Intervention: Tympanic thermometer
Number of subjects: 0

Group type: COMPARATOR
Intervention: Oral and axillary thermometers
Number of subjects: 0
Study: 16536107

Group type: EXPERIMENTAL
Intervention: Intrathecal fentanyl 20 microg (Group F)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Normal saline 0.4 ml (Group S)
Number of subjects: 60
Study: 12426644

Group type: EXPERIMENTAL
Intervention: Exercise training program (3 sessions per week for 3 months)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Control group (no exercise training)
Number of subjects: 24
Study: 10526804

Group type: EXPERIMENTAL
Intervention: Active forced-air warming of the two upper limbs (Group Upper body, n = 24)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Active forced-air warming of the unoperated lower limb (Group Lower extremity, n = 24)
Number of subjects: 48
Study: 7791060

Group type: EXPERIMENTAL
Intervention: Diclofenac sodium (Voltaren Ophthalmic)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Flurbiprofen (Ocufen)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Incision size (5.2 mm versus 7.0 mm)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Intraocular carbachol (Miostat)
Number of subjects: 200
Study: 2028533

Group type: EXPERIMENTAL
Intervention: Single daily dose of metoprolol
Number of subjects: 1153

Group type: COMPARATOR
Intervention: Single daily dose of metoprolol plus a single dose of placebo
Number of subjects: 1153
Study: 6689389

Group type: EXPERIMENTAL
Intervention: Isosorbide dinitrate (ISDN) 20 mg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Isosorbide dinitrate (ISDN) 3 X 20 mg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Isosorbide dinitrate (ISDN) 3 X 60 mg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Nifedipine 3 X 20 mg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: High doses of Isosorbide dinitrate (ISDN)
Number of subjects: 0
Study: 29741962

Group type: EXPERIMENTAL
Intervention: MSWDQ‐23
Number of subjects: 124
Study: 28727540

Group type: EXPERIMENTAL
Intervention: Patient navigation by a community health worker for CRC screening (PN)
Number of subjects: 731

Group type: EXPERIMENTAL
Intervention: Both interventions (PLUS)
Number of subjects: 731

Group type: COMPARATOR
Intervention: Motivational interviewing for blood pressure control by a trained counselor (MINT)
Number of subjects: 731
Study: 25899119

Group type: EXPERIMENTAL
Intervention: Middle meatal silastic stent
Number of subjects: 36

Group type: COMPARATOR
Intervention: Control (no stent)
Number of subjects: 36
Study: 24385406

Group type: EXPERIMENTAL
Intervention: Sublingual fentanyl (SLF)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Oral morphine (OM)
Number of subjects: 40
Study: 23016517

Group type: EXPERIMENTAL
Intervention: Weekly docetaxel at 20 mg/m(2)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Weekly docetaxel at 10 mg/m(2) and 15 mg/m(2)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: High-dose intensity-modulated radiation therapy (IMRT) at 78 Gy
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Androgen-deprivation therapy (ADT)
Number of subjects: 18
Study: 19147446

Group type: EXPERIMENTAL
Intervention: Cardiac resynchronization therapy (CRT)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Cardiac resynchronization therapy with atrial overdrive pacing (CRT + AOP)
Number of subjects: 30
Study: 17540811

Group type: EXPERIMENTAL
Intervention: Global endometrial ablation (thermal balloon ablation technology or bipolar radiofrequency ablation technology)
Number of subjects: 41
Study: 15130569

Group type: EXPERIMENTAL
Intervention: Relaxation acupoint stimulation followed by acupressure with lavender oil (8 sessions over 3 weeks)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 0
Study: 11207153

Group type: EXPERIMENTAL
Intervention: Unfiltered coffee consumption
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Filtered coffee consumption
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Caffeinated or boiled coffee consumption
Number of subjects: 14

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 14
Study: 9701432

Group type: EXPERIMENTAL
Intervention: Salbutamol (100 microg x puff(‐1)) with end-inspiratory pause (EIP) of 5 s
Number of subjects: 12

Group type: COMPARATOR
Intervention: Salbutamol (100 microg x puff(‐1)) without end-inspiratory pause (EIP)
Number of subjects: 12
Study: 7974337

Group type: EXPERIMENTAL
Intervention: Preoperative and postoperative measurements of Prothrombin Fragment 1 + 2 (F1 + 2)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Preoperative and postoperative measurements of Thrombin‐antithrombin III complex (TAT)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Preoperative and postoperative measurements of Fibrinopeptide A (FpA)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Preoperative and postoperative measurements of Fibrin and Fibrinogen Degradation Products (FbDP)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Preoperative and postoperative measurements of Soluble Fibrin (SF)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Preoperative and postoperative measurements of Fibrinogen Degradation Products (FgDP)
Number of subjects: 40
Study: 2684804

Group type: EXPERIMENTAL
Intervention: 2 g olsalazine
Number of subjects: 105

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 105
Study: 769630

Group type: EXPERIMENTAL
Intervention: Classic acupuncture
Number of subjects: 42

Group type: COMPARATOR
Intervention: Placebo (needles did not penetrate the skin)
Number of subjects: 42
Study: 31358702

Group type: COMPARATOR
Intervention: Single session of transcutaneous vagus nerve stimulation (tVNS)
Number of subjects: 94

Group type: EXPERIMENTAL
Intervention: Daily transcutaneous vagus nerve stimulation (tVNS) for two weeks
Number of subjects: 94
Study: 28806904

Group type: EXPERIMENTAL
Intervention: Falls prevention programme based on the Otago Exercise Programme, lasting 12 weeks including home visits and motivational telephone calls.
Number of subjects: 150

Group type: COMPARATOR
Intervention: Usual care (control group).
Number of subjects: 150
Study: 26098128

Group type: EXPERIMENTAL
Intervention: Rosa damascena oil
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study: 26866103

Group type: EXPERIMENTAL
Intervention: TPN with omega 3 fatty acid solution (S-O group)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: TPN with glutamine solution (S-D group)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: TPN with omega 3 fatty acids solution and glutamine (S-D-O group)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Standard TPN (Control group)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: All study groups (including S-D, S-O, S-D-O)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 36
Study: 21384285

Group type: EXPERIMENTAL
Intervention: Intervention group (n=22) received a home visit by a HF-nurse and 17 telephone calls over 12 months focusing on self-care.
Number of subjects: 42

Group type: COMPARATOR
Intervention: Usual care group (n=20) received standard medical treatment and lifestyle recommendations without additional support.
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Intervention group (n=22)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Usual care group (n=20)
Number of subjects: 42
Study: 19730881

Group type: EXPERIMENTAL
Intervention: Drain placement
Number of subjects: 160

Group type: COMPARATOR
Intervention: No drain placement
Number of subjects: 160
Study: 17277576

Group type: EXPERIMENTAL
Intervention: Train-of-five technique (direct cortical stimulation)
Number of subjects: 129

Group type: COMPARATOR
Intervention: 60-Hz technique (direct cortical stimulation)
Number of subjects: 129

Group type: COMPARATOR
Intervention: Control group (patients without symptomatic epilepsy)
Number of subjects: 129
Study: 15015439

Group type: EXPERIMENTAL
Intervention: Jiawei Yupingfeng Powder (JYP) administered additionally for 14 days
Number of subjects: 84

Group type: COMPARATOR
Intervention: Conventional western medicinal therapy
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: Jiawei Yupingfeng Powder (JYP)
Number of subjects: 84
Study: 11440911

Group type: EXPERIMENTAL
Intervention: High protein intake (1.5 g x kg(‐1) x day(‐1))
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Low protein intake (0.3 g. kg(‐1) x day(‐1))
Number of subjects: 12

Group type: COMPARATOR
Intervention: Customary high-protein diet (for diabetic subjects)
Number of subjects: 12
Study: 9602576

Group type: EXPERIMENTAL
Intervention: Morphine mixed with 1% propofol
Number of subjects: 50

Group type: COMPARATOR
Intervention: Morphine mixed with lvelip
Number of subjects: 50
Study: 7800581

Group type: EXPERIMENTAL
Intervention: Misoprostol (MI) 400 mg
Number of subjects: 15

Group type: COMPARATOR
Intervention: Placebo (PL)
Number of subjects: 15
Study: 3055791

Group type: EXPERIMENTAL
Intervention: Bupivacaine (2 mg/kg) administered intraperitoneally 10 min before surgery (n = 9)
Number of subjects: 19

Group type: COMPARATOR
Intervention: Saline administered intraperitoneally (n = 10)
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Bupivacaine (2 mg/kg)
Number of subjects: 19

Group type: COMPARATOR
Intervention: Saline
Number of subjects: 19
Study: 29990679

Group type: EXPERIMENTAL
Intervention: Mobile video-based CBT
Number of subjects: 5
Study: 27931552

Group type: EXPERIMENTAL
Intervention: Trimetazidine 35mg sustained release tablet, twice daily
Number of subjects: 98

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 98
Study: 25262254

Group type: EXPERIMENTAL
Intervention: Ranolazine
Number of subjects: 913

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 913
Study: 23328596

Group type: EXPERIMENTAL
Intervention: Trastuzumab (1 year)
Number of subjects: 122

Group type: COMPARATOR
Intervention: Observation (1 year)
Number of subjects: 122
Study: 19951297

Group type: EXPERIMENTAL
Intervention: Brief motivational intervention with ethnic match
Number of subjects: 537

Group type: COMPARATOR
Intervention: Brief motivational intervention without ethnic match
Number of subjects: 537

Group type: COMPARATOR
Intervention: Treatment as usual
Number of subjects: 537
Study: 18096287

Group type: EXPERIMENTAL
Intervention: risperidone 6 mg/day plus propentofylline 900 mg/day (300 mg TDS)
Number of subjects: 50

Group type: COMPARATOR
Intervention: risperidone 6 mg/day plus placebo
Number of subjects: 50
Study: 15669881

Group type: EXPERIMENTAL
Intervention: Tenofovir disoproxil fumarate (tenofovir DF) 300 mg once daily
Number of subjects: 0
Study: 12428176

Group type: EXPERIMENTAL
Intervention: Boron supplementation (11.6 mg boron as 102.6 mg sodium tetraborate decahydrate)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Boron supplementation (11.6 mg boron)
Number of subjects: 15
Study: 10350016

Group type: EXPERIMENTAL
Intervention: High-calorie protein meal
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: High-calorie carbohydrate meal
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: High-calorie fat meal
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Non-caloric hydroxypropylmethyl cellulose (HPMC) viscous meal
Number of subjects: 7

Group type: COMPARATOR
Intervention: Fasted control
Number of subjects: 7
Study: 8647571

Group type: EXPERIMENTAL
Intervention: Ginkgo biloba
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Ginkgo biloba combined with walking exercise
Number of subjects: 10
Study: 1685362

Group type: EXPERIMENTAL
Intervention: Indapamide (diuretic)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Doxazosin (alpha 1‐blocker)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Slow-release nifedipine (calcium blocker)
Number of subjects: 0
Study: 6158478

Group type: EXPERIMENTAL
Intervention: SQ 20,881
Number of subjects: 31

Group type: COMPARATOR
Intervention: SQ 14,225
Number of subjects: 31
Study: 30789027

Group type: EXPERIMENTAL
Intervention: RCC training program alone
Number of subjects: 92

Group type: EXPERIMENTAL
Intervention: RCC training program plus support
Number of subjects: 92

Group type: COMPARATOR
Intervention: Care as usual
Number of subjects: 92
Study: 30548889

Group type: EXPERIMENTAL
Intervention: Cognitive training in reasoning, processing speed, memory
Number of subjects: 2802

Group type: COMPARATOR
Intervention: No-contact control condition
Number of subjects: 2802
Study: 27472929

Group type: EXPERIMENTAL
Intervention: 130g/day low-carbohydrate diet (LCD)
Number of subjects: 66

Group type: COMPARATOR
Intervention: Calorie restricted diet (CRD)
Number of subjects: 66
Study: 26291542

Group type: EXPERIMENTAL
Intervention: One-legged cycling training (15 minutes with each leg, three times per week for 6-8 weeks)
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: One-legged cycling training
Number of subjects: 22
Study: 23803893

Group type: EXPERIMENTAL
Intervention: Regular activity breaks (walking for 1 min 40 s every 30 min)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Physical activity (walking for 30 min and then sitting)
Number of subjects: 70
Study: 21852659

Group type: EXPERIMENTAL
Intervention: After-school health education and physical activity program (12 weeks, twice a week)
Number of subjects: 901

Group type: COMPARATOR
Intervention: Spillover effects from intervention participants to nonparticipants
Number of subjects: 901
Study: 19297786

Group type: EXPERIMENTAL
Intervention: Pneumatic wound compression
Number of subjects: 288

Group type: COMPARATOR
Intervention: No compression (control)
Number of subjects: 288
Study: 17173278

Group type: EXPERIMENTAL
Intervention: Paricalcitol (16 microg) alone (regimen A)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Paricalcitol (16 microg) with omeprazole (40 mg) (regimen B)
Number of subjects: 26
Study: 15887905

Group type: EXPERIMENTAL
Intervention: Previously injured players (ankle or knee ligament injury)
Number of subjects: 216

Group type: EXPERIMENTAL
Intervention: Previously injured limb
Number of subjects: 216

Group type: COMPARATOR
Intervention: Players with no previous lower limb ligament injury
Number of subjects: 216
Study: 12926190

Group type: EXPERIMENTAL
Intervention: Carbamazepine
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Phenytoin
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Lamotrigine
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Phenobarbital
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Sodium valproate
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Felbamate
Number of subjects: 15

Group type: COMPARATOR
Intervention: Topiramate
Number of subjects: 15

Group type: COMPARATOR
Intervention: Vigabatrin
Number of subjects: 15

Group type: COMPARATOR
Intervention: Clonazepam
Number of subjects: 15

Group type: COMPARATOR
Intervention: Gabapentin
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Eosinophilia
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Elevated liver enzymes
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Skin biopsies
Number of subjects: 15
Study: 10682457

Group type: EXPERIMENTAL
Intervention: Mifepristone 10 mg/daily for 3 months
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control (no mifepristone treatment)
Number of subjects: 20
Study: 7741987

Group type: EXPERIMENTAL
Intervention: Maximal surgical endeavour aimed at cytoreduction
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard practice of cytoreduction
Number of subjects: 0
Study: 2616602

Group type: EXPERIMENTAL
Intervention: Bromocriptine 2.5 mg
Number of subjects: 9

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Cocaine 40 mg IV
Number of subjects: 9
Study: 84761

Group type: EXPERIMENTAL
Intervention: Procainamide (Pronestyl)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: N-acetylprocainamide (Duretter)
Number of subjects: 18
Study: 28462467

Group type: EXPERIMENTAL
Intervention: CT-based attenuation correction (AC)
Number of subjects: 312

Group type: COMPARATOR
Intervention: Non-AC (NAC)
Number of subjects: 312
Study: 29236569

Group type: EXPERIMENTAL
Intervention: Two-way text messaging engagement during the first 2 weeks postpartum
Number of subjects: 0
Study: 27399141

Group type: EXPERIMENTAL
Intervention: Ornidazole-based regimen
Number of subjects: 200

Group type: COMPARATOR
Intervention: Metronidazole-based regimen
Number of subjects: 200
Study: 23625140

Group type: EXPERIMENTAL
Intervention: Community engagement and collaborative planning intervention
Number of subjects: 0
Study: 22906943

Group type: EXPERIMENTAL
Intervention: Adjuvanted vaccine (3.8 µg or 7.5 µg HA)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Non-adjuvanted vaccine (15 µg HA)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Adjuvanted vaccine (1.9 µg or 3.8 µg HA)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Non-adjuvanted vaccine (7.5 µg HA)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Adjuvanted vaccine
Number of subjects: 0
Study: 19374793

Group type: EXPERIMENTAL
Intervention: Carbapenem restriction
Number of subjects: 26

Group type: COMPARATOR
Intervention: Conventional treatment
Number of subjects: 26
Study: 17573885

Group type: EXPERIMENTAL
Intervention: Pimecrolimus cream 1% (twice daily) + Fluticasone propionate cream 0.05% (once daily)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Vehicle (twice daily) + Fluticasone propionate cream 0.05% (once daily)
Number of subjects: 45
Study: 15068193

Group type: EXPERIMENTAL
Intervention: Adaptive software
Number of subjects: 16

Group type: COMPARATOR
Intervention: Current head-control system
Number of subjects: 16